1146853

REATA PHARMACEUTICALS — FEI 3017110172

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 13, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plano, TX (United States)

Additional Details

Sponsor, Contract Research Organization